USE OF TARAMANDUR GUD FOR TREATING PANDU DISEASE (IRON DEFICIENCY ANEMIA)

PHARMACEUTICO-ANALYTICAL STUDY AND CLINICAL EVALUATION OF TARAMANDUR GUD W.S.R. TO PANDU ROGA (IRON DEFICIENCY ANEMIA) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096056

Enrollment

Registered

2025-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z679- Unspecified blood type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Sign and symptoms of Anaemia. Evidence of Anaemia by lab investigations. Participates in age group of 18-70 years. Patients with Anaemia between 06gm percent-10gm percent of Haemoglobin

Exclusion criteria

Exclusion criteria: Patients suffered with serious cardiac disorders like Mi, Cardiac failure and Crisis Patients having life threatening disease. Patient having major illness like IDDM, DM which is poorly controlled or newly diagnosed or is taking new therapy or recently adjusted therapy. Patient having Carcinoma, Pregnant lady. Patient with severe Anaemia below 06 gm% of Haemoglobin. Patient suffering with Thalassemia, Bone marrow disorders. Autoimmune disorders and Iron toxicity. Patient himself or hersell wants to withdraw from the clinical trial

Design outcomes

Primary

Measure	Time frame
change in quantity of haemoglobin.Timepoint: 60 days	—

Secondary

Measure	Time frame
anemia scale will be assessedTimepoint: 15 days, 30 days, and 45 days	—

Countries

India

Contacts

Public ContactDR ANITA KUMARI MEENA

MMM Goverment Ayurveda College Udaipur

sharmadrajay@yahoo.com9413257535

Outcome results